Abstract:Aim : creation of a method for predicting the development of varicose veins of the lower extremities and its recurrence. Object and methods . 2 independent studies of patients with C2-C6 varicose veins of the lower extremities (CEAP-classifier) were conducted. In the first, with ultrasound diagnosis of the main veins of the lower extremities and genomic analysis of blood samples, 75 participants (men 20, women 55), mean age 43.7 ± 5.9 years. All patients were randomized into two groups: group I (n = 17) – with recurrent varicose veins; Group II (n = 58) – applied with varicose veins for the first time. The 2nd study involved 44 (men 10, women 34), mean age 55.5 ± 2.7 years. Similarly, patients were divided into groups – I (5) and II (39 people). All patients of the first stage of the study underwent real-time PCR with allele-specific primers to determine the A82G mutation in the MMP-12 gene (matrix metalloproteinase-12) and the second stage C634G in the VEGF-A gene (endothelial fibroblast growth factor – A). Results of the study . In patients of both groups I and II, having the MMP-12 gene in the heterozygous variant, dilatation of the tibial and popliteal veins was present (6.4 ± 0.3 mm and 10.7 ± 0.24 mm, respectively) with the presence reflux and slowing down the evacuation of blood from the deep venous system. In patients of group I, the MMP-12 gene was found in 80 % of cases, as A/A (homozygous) and A/G (heterozygous variation), while in group II only in 33.3 % of cases. Pearson's goodness-of-fit criterion χ2 = 10.4 (the critical value of the criterion is 6.63), p < 0.01. The frequency of recurrence of varicose veins and mutation of the MMP-12 gene according to the Spearman test was 1.0 with the number of degrees of freedom 23, p < 0.05. In the 2nd study, a correlation was found between groups I and II of patients with the C/C genotype (Pearson's coefficient χ2 = 0.79, p < 0.11) and a correlation in the duration of the disease between groups of patients with the C/C genotype (homozygous variation) and C /G (heterozygous variation) – Pearson correlation coefficient χ2 = 0.92 (p < 0.01). Conclusion . The revealed relationship between the MMP-12 gene polymorphism and the frequency of varicose vein recurrence is a predictor of the development of structural changes in the vein wall, and a mutation in the VEGF-A gene occurs with a long history of the disease.

Polymorphisms in MMP-9 and TIMP-2 in Chinese patients with varicose veins

Polymorphism of Metalloproteinases and Inhibitors of Matalloproteinases in Patients with Varicose Veins

Correlation Study of Tissue Inhibitor of Matrix Metalloproteinase-1 Gene Polymorphisms and Chronic Periodontitis

Polymorphism of matrix metalloproteinase genes (MMP1 and MMP3) in patients with varicose veins

[The Correlation Between Polymorphisms of Matrix Metalloproteinase-2 and -9 Genes and Colorectal Cancer of Chinese Patients].

Association of Matrix Metalloproteinase‐2 and ‐9 Promoter Polymorphisms with Colorectal Cancer in Chinese

Relationship Between IL-10 Promoter Gene Polymorphisms and the Susceptibility to Endometriosis

The effect of the A82G mutation in the MMP-12 gene and C634G mutation in the VEGF-A gene on the course of lower limb varicose veins and the risk of disease recurrence

Association Between Polymorphism of C936T in Vascular Endothelial Growth Factor Gene and Type 2 Diabetic Nephropathy

Variations in Matrix Metalloproteinase-1, -3, and -9 Genes and the Risk of Acute Coronary Syndrome and Coronary Artery Disease in the Chinese Han Population.

A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-2 Promoter is Associated with Colorectal Cancer.

No Association Between the Polymorphisms in Matrix Metalloproteinase-1 and Matrix Metalloproteinase-3 Promoter Regions and Colorectal Cancer in Chinese

Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer

Role of Matrix Metalloproteases 1/3 Gene Polymorphisms in Patients with Rotator Cuff Tear

A Meta-Analysis of MMP-9 Promoter −1562 C/T Polymorphism on Susceptibility of Chronic Periodontitis

Matrix Metalloproteinase-2 Promoter And Tissue Inhibitor Of Metalloproteinase-2 Gene Polymorphisms In Non-Hodgkin'S Lymphoma

A genome-wide association study for varicose veins

Polymorphism of angiogenesis regulation factor genes (VEGF/VEGFR), and extracellular matrix remodeling genes (MMP/TIMP), and the levels of their products in extracellular tissues of patients with primary and secondary lymphedema

Correlation of Matrix Metalloproteinase-2 Single Nucleotide Polymorphisms with the Risk of Small Vessel Disease (SVD)

Epidemiological Evidence Between Variants in Matrix Metalloproteinases-2, -7, and -9 and Cancer Risk

Meta-Analysis of Associations Between Polymorphisms in the Promoter Regions of Matrix Metalloproteinases and the Risk of Colorectal Cancer